首页> 外文期刊>Inorganic Chemistry: A Research Journal that Includes Bioinorganic, Catalytic, Organometallic, Solid-State, and Synthetic Chemistry and Reaction Dynamics >Activation of carbodiimide and transformation with amine to guanidinate group by Ln(OAr)_3(THF)_2 (Ln: Lanthanide and yttrium) and Ln(OAr)_3(THF)_2 as a novel precatalyst for addition of amines to carbodiimides: Influence of aryloxide group
【24h】

Activation of carbodiimide and transformation with amine to guanidinate group by Ln(OAr)_3(THF)_2 (Ln: Lanthanide and yttrium) and Ln(OAr)_3(THF)_2 as a novel precatalyst for addition of amines to carbodiimides: Influence of aryloxide group

机译:Ln(OAr)_3(THF)_2(Ln:镧系元素和钇)和Ln(OAr)_3(THF)_2作为向碳二亚胺中添加胺的新型预催化剂,活化碳二亚胺并用胺将其转化为胍基基团:芳氧基

获取原文
获取原文并翻译 | 示例
           

摘要

Reaction of Ln(OAr~1)_3(THF)_2 (Ar ~1= [2,6-(tBu)2- 4-MeC_6H_2] with carbodiimides (RNCNR) in toluene afforded the RNCNR coordinated complexes (Ar ~1O)_3Ln(NCNR) (R = iPr (isopropyl), Ln = Y (1) andYb (2); R = Cy (cyclohexyl), Ln = Y (3)) in high yields. Treatment of 1 and 2 with 4-chloroaniline, respectively, at a molar ratio of 1:1 yielded the corresponding monoguanidinate complex (Ar~1O)2Y[(4-Cl-C6H4N)C(NHiPr) N ~iPr](THF) (4) and (Ar~1O)_2Yb[(4-Cl-C _6H_4N)C(NH~iPr)N~iPr] (THF) (5). Complexes 4 and 5 can be prepared by the reaction of Ln(OAr~1)3(THF)2 with RNCNR and amine in toluene at a 1:1:1 molar ratio in high yield directly. A remarkable influence of the aryloxide ligand on this transformation was observed. The similar transformation using the less bulky yttrium complexes Y(OAr~2)3(THF)2 (Ar~2 = [2,6-(i Pr)2C6H3]) or Y(OAr _2)_3(THF)_2 (Ar~3 = [2,6- Me _2C_6H_3]) did not occur. Complexes Ln(OAr ~1)3(THF)2 were found to be the novel precatalysts for addition of RNCNR with amines, which represents the first example of catalytic guanylation by the lanthanide complexeswith the Ln-O active group.The catalytic activity of Y(OAr~1)3(THF)_2 was found to be the same as that of monoguanidinate complex 4, indicating 4 is one of the active intermediates in the present process. The other intermediate, amide complex (Ar ~1O)_2Ln[(2-OCH_3-C_6H _4NH)(2-OCH3-C6H4NH2)] (6), was isolated by protonolysis of 4 with 2-OCH_3-C_6H_4NH_2. All the complexes were structurally characterized by X-ray single crystal determination.
机译:Ln(OAr〜1)_3(THF)_2(Ar〜1 = [2,6-(tBu)2-4-MeC_6H_2]与碳二亚胺(RNCNR)在甲苯中的反应得到RNCNR配位化合物(Ar〜1O)_3Ln (NCNR)(R = iPr(异丙基),Ln = Y(1)和Yb(2); R = Cy(环己基),Ln = Y(3))高产率。用4-氯苯胺处理1和2,分别以1:1的摩尔比生成相应的单胍盐配合物(Ar〜1O)2Y [(4-Cl-C6H4N)C(NHiPr)N〜iPr](THF)(4)和(Ar〜1O)_2Yb [(4-Cl-C _6H_4N)C(NH〜iPr)N〜iPr](THF)(5)。配合物4和5可通过Ln(OAr〜1)3(THF)2与RNCNR的反应制备直接与甲苯中的胺以1:1:1的摩尔比直接高收率,观察到芳氧基配体对此转化有显着影响,使用体积较小的钇配合物Y(OAr〜2)3(THF)进行相似的转化没有出现2(Ar〜2 = [2,6-(i Pr)2C6H3])或Y(OAr _2)_3(THF)_2(Ar〜3 = [2,6-Me _2C_6H_3])。发现OAr〜1)3(THF)2是将RNCNR与胺加成的新型预催化剂代表了具有Ln-O活性基团的镧系元素配合物催化鸟嘌呤化的第一个实例。发现Y(OAr〜1)3(THF)_2的催化活性与单胍盐配合物4相同,表明4是本发明方法中的活性中间体之一。另一中间体酰胺络合物(Ar〜1O)_2Ln [(2-OCH_3-C_6H _4NH)(2-OCH3-C6H4NH2)](6)通过2-OCH_3-C_6H_4NH_2的4质子分离得到。通过X射线单晶测定对所有配合物进行结构表征。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号